03/06/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:48 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:49 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
6:32 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
6:36 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
8:36 AM | Adage Capital Management, L.P. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:34 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:03 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:07 PM | Karyopharm Therapeutics (Issuer)
Macomber Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for KPTI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/02/2025
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:35 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:50 PM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:49 AM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G | |
09/05/2024
3:28 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:13 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:24 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:26 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:31 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:33 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:42 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:14 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:07 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-I/A | |
07/09/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
06/20/2024
7:01 AM | Karyopharm Therapeutics (Subject)
| Form SC TO-I | |
06/09/2024
11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
06/07/2024
6:18 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:51 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Please don’t die on me (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune.
After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life |
05/30/2024
4:19 PM | BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:25 PM | Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:32 PM | Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:44 PM | Karyopharm Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2024
3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:13 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:52 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:56 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
6:55 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/19/2024
6:36 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
6:44 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024
4:08 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-C | |
04/08/2024
3:40 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
04/05/2024
4:20 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free KPTI Stock Alerts